By Bhanvi Satija LONDON, Feb 2 (Reuters) - French drugmaker Sanofi said on Monday that its experimental genetic disorder ...
Stocktwits on MSN
Regeneron stock slips premarket even after Wall Street lifts targets on strong Q4 — what’s weighing on the stock?
Several Wall Street firms raised price targets on Regeneron after its Q4 results. ・Q4 revenue and non-GAAP earnings both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results